n-methyl-3,4-methylenedioxyamphetamine has been researched along with Heart Septal Defects, Ventricular in 1 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Increased risk of ventricular septal defect was found to be associated with consumption of cough and cold remedies [pre-conception OR 2." | 1.32 | A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England. ( Bateman, DN; Dickinson, D; Matthews, JN; McElhatton, PR; O'Keeffe, M; Thomas, SH; Wren, C, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bateman, DN | 1 |
| McElhatton, PR | 1 |
| Dickinson, D | 1 |
| Wren, C | 1 |
| Matthews, JN | 1 |
| O'Keeffe, M | 1 |
| Thomas, SH | 1 |
1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England.
Topics: Adolescent; Adult; Amphetamines; Birth Weight; Case-Control Studies; Cohort Studies; Drug-Related Si | 2004 |